The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for Metastatic Breast Cancer
Sites in Gilbert, Mesa +71 more locations
Sponsor: American Society of Clinical Oncology
Sex: All·Age: 65+
Code: NCT06377852·Phase 3·Recruiting·Listed Apr 2024
Oncology Clinical Trials in Gilbert, AZ
As of July 2026, 53 paid clinical trials are recruiting for Oncology in Gilbert, Arizona. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
54 clinical trials for Oncology
·Clear filters·↓ Download CSVTesting the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Sites in Gilbert, Tempe +144 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT06532279·Phase 2·Recruiting·Listed Aug 2024
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
for Breast Cancer
Sites in Gilbert, Tempe +635 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18 - 100
Code: NCT05896189·Recruiting·Listed Jun 2023
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for Head and Neck Squamous Cell Carcinoma
Sites in Gilbert, Tempe +167 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT06992427·Phase 3·Recruiting·Listed May 2025
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for Hematologic Malignancies
Sites in Gilbert, Phoenix +111 more locations
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All·Age: All ages
Code: NCT01351545·Recruiting·Listed May 2011
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
for Non-small Cell Lung Cancer
Sites in Gilbert +19 more locations
Sponsor: Institut de Recherches Internationales Servier
Sex: All·Age: 18+
Code: NCT05786924·Phase 1, Phase 2·Recruiting·Listed Mar 2023
PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER
for Gastric Adenocarcinoma
1 location in Gilbert
Sponsor: Banner Health
Sex: All·Age: 18+
Code: NCT07178808·Phase 2·Recruiting·Listed Sep 2025
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
for Inflammatory Breast Carcinoma
Sites in Gilbert +7 more locations
Sponsor: M.D. Anderson Cancer Center
Sex: All·Age: 18+
Code: NCT00477100·Recruiting·Listed May 2007
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for Metastatic Clear Cell Renal Cell Carcinoma
Sites in Gilbert, Tucson +338 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT04510597·Phase 3·Recruiting·Listed Aug 2020
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for Non-small Cell Lung Cancer (NSCLC)
Sites in Gilbert, Chandler +46 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07291037·Phase 3·Recruiting·Listed Dec 2025
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
for Non-small Cell Lung Cancer
Sites in Gilbert +13 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT05877599·Phase 1·Recruiting·Listed May 2023
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for Advanced Breast Cancer
Drug: Camizestrant
Sites in Gilbert +38 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06380751·Phase 3·Recruiting·Listed Apr 2024
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
for Barrett Esophagus
Sites in Gilbert +13 more locations
Sponsor: University of Colorado, Denver
Sex: All·Age: 18 - 89
Code: NCT05530343·Recruiting·Listed Sep 2022
Conditions in Oncology (Gilbert, AZ)
Breast cancer· 10Non-small cell lung cancer (NSCLC)· 9Colorectal cancer· 9Solid tumor· 7Metastatic breast cancer· 5Pancreatic cancer· 5Head and neck cancer· 5Ovarian cancer· 4Multiple myeloma· 4Non-Hodgkin lymphoma· 4Cancer (any)· 4Lung cancer· 3Diffuse large B-cell lymphoma (DLBCL)· 3Hematologic malignancy· 3Mesothelioma· 3Colon cancer· 2Rectal cancer· 2Metastatic prostate cancer· 2Kidney cancer· 2Acute myeloid leukemia (AML)· 2Chronic lymphocytic leukemia (CLL)· 2Triple-negative breast cancer· 1HER2-negative breast cancer· 1Gastric cancer· 1Esophageal cancer· 1Prostate cancer· 1Bladder cancer· 1Brain metastases· 1Leukemia (other)· 1Myelodysplastic syndromes (MDS)· 1Myelofibrosis· 1Hodgkin lymphoma· 1Follicular lymphoma· 1Mantle cell lymphoma· 1Small lymphocytic lymphoma· 1Burkitt lymphoma· 1Melanoma· 1Skin cancer· 1Thyroid cancer· 1